⭐ Top Story
Cannabis Stocks Tuesday July 28 2026 Morning Brief August Earnings Acceleration Begins as GTBIF August 4 and CURLF August 5 Define Sector Inflection Window
TL;DR: Cannabis equities enter Tuesday’s session absorbing Tilray’s Q4 FY2026 print and positioning ahead of what will be the most concentrated earnings window of summer
Tilray Brands TLRY Tuesday July 28 2026 Earnings Reaction Q4 FY2026 Results Test Diversification Thesis as Market Weighs Beer Revenue Against Cannabis Trajectory
TL;DR: Tilray Brands reported Q4 FY2026 results before Monday’s market open, delivering a mixed picture that kept the stock under pressure near its 52-week low
Curaleaf Holdings CURLF Monday Evening July 27 2026 Earnings Preview as Largest US MSO by Revenue Sets August 5 Catalyst Against Strong YTD Backdrop
TL;DR: Curaleaf Holdings (CURLF: OTC) enters the final sessions before its August 5 earnings date with year-to-date gains of 22.7%, a one-year return of 158.5%,
TerrAscend TRSSF Monday July 27 2026 MSO Update Pennsylvania and New Jersey Anchor Q2 2026 Path as US Canada Operator Targets Return to Profitability Ahead of August Earnings Season
TL;DR: TerrAscend Corp (OTC: TRSSF) is navigating Monday’s midday session as the US-Canada multi-state operator holds near recent support levels ahead of what management has
AYR Wellness AYRWF Monday July 27 2026 Midday Analysis Southeast MSO Advances Profitability Mandate as Debt Restructuring Progress and Florida Market Strength Set Up Q2 2026 Reporting Season
TL;DR: AYR Wellness (OTC: AYRWF) is holding near its Q2 intraday range as the multi-state operator continues to execute a multi-quarter cost rationalization program targeting
Organigram Holdings OGI Monday July 27 2026 Morning Market Brief Canadian LP Posts 3 Percent Gain as August Earnings Approach and YTD Outperformance Signals Sector Rotation
TL;DR: Organigram Holdings (NASDAQ: OGI) posted a notable +3.27% gain on Monday, July 27, closing at $0.9293 after opening at $0.9015. The Canadian licensed producer
📈 Top Movers
Tilray Brands TLRY Tuesday July 28 2026 Earnings Reaction Q4 FY2026 Results Test Diversification Thesis as Market Weighs Beer Revenue Against Cannabis Trajectory
TL;DR: Tilray Brands reported Q4 FY2026 results before Monday’s market open, delivering a mixed picture that kept the stock under pressure near its 52-week low
Curaleaf Holdings CURLF Saturday July 25 2026 Midday Analysis Largest US Cannabis Operator Advances Profitability Mandate as Retail Network and Q2 Reporting Season Approach
TL;DR: Curaleaf Holdings (OTC: CURLF / CSE: CURA) — the operator of the largest retail cannabis dispensary network in the United States — enters the
Tilray Brands TLRY Saturday July 25 2026 Pre-Earnings Brief Three Trading Days to Q4 FY2026 Results as International Cannabis and Beverage Revenue Define the Story
TL;DR: Tilray Brands (NASDAQ: TLRY) enters the final weekend before its Q4 FY2026 earnings report — scheduled for Tuesday, July 28 — trading near $4.26
Organigram Holdings OGI Thursday July 23 2026 Midday Analysis Canadian LP Gains 3 Percent as BAT Partnership and International Expansion Drive Institutional Interest Ahead of August 11 Earnings
TL;DR: Organigram Holdings (OGI) gained 3.27% on Thursday to close at $0.9293, extending a year-to-date rally of 45.34% that has substantially outpaced the broader S&P/TSX
Glass House Brands GLASF Wednesday July 22 2026 Midday Update California Cultivator Holds Near 52 Week High After 159 Percent Rally as Low Cost Greenhouse Model Draws Institutional Interest
TL;DR: Glass House Brands (OTC: GLASF) trades at $11.81 Wednesday midday, within 15% of its 52-week high of $13.93 and representing a 159% advance from
Trulieve Cannabis TCNNF Wednesday July 22 2026 Midday Analysis Florida MSO Trades at 8.84 as Recreational Market Momentum Builds Ahead of Q2 Reporting Season
TL;DR: Trulieve Cannabis (OTC: TCNNF) holds at $8.84 midday Wednesday, approximately 33% below its 52-week high as Florida’s largest multi-state operator navigates the transition from
📰 Today's News
Curaleaf Shareholders Approve Delaware Redomicile, Clearing a Key Hurdle Toward U.S. Exchange Uplisting
TL;DR: Curaleaf Holdings shareholders voted on June 22 to approve the company’s continuation as a Delaware corporation, a structural step that repositions the largest U.S.
DEA Judge Finalizes Cannabis Rescheduling Hearing Timeline as MSOS Sector Holds 2026 Highs
TL;DR: A Drug Enforcement Administration administrative law judge formally set the hearing schedule for cannabis rescheduling proceedings today, June 25, signaling that the multi-year regulatory
Cultivation Consolidation Wave: Which Operators Win?
By Sheeba M. | June 16, 2026 Consolidation Wave: Which Operators Win? TL;DR: Oversupply forces consolidation; winners have efficient cultivation tech and scale. The cannabis
Cannabis Stocks Rally on FDA Approval Signals
By Sheeba M. | June 16, 2026 Cannabis Stocks Rally on FDA Approval Signals TL;DR: Federal agencies hint at accelerated CBD approvals, unlocking $2B+ for
SAFE Act Delays Push Federal Legalization Timeline to 2027
By Sheeba M. | June 16, 2026 SAFE Act Delays Push Federal Legalization Timeline to 2027 TL;DR: Congressional delays in the SAFE Act schedule suggest
State Cannabis Sales Climb to Record $17.5B in 2026 H1
By Sheeba M. | June 16, 2026 State Cannabis Sales Climb to Record $17.5B in 2026 H1 TL;DR: Legal cannabis sales reached $17.5 billion in